Daptomycin 350 mg/7mL (Daptomycin INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION) 350 mg/7mL

Daptomycin 350 mg/7mL is a lyophilized powder for intravenous solution, used primarily for bacterial infections. This antibiotic is effective against certain gram-positive bacteria, including those resistant to other treatments.

Strength

350 mg/7mL

Pack Size

1 VIAL in 1 CARTON (25021-179-66) / 7 mL in 1 VIAL

Manufacturer / TM Owner

Sagent Pharmaceuticals

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Daptomycin is commonly used to treat complicated skin and skin structure infections caused by susceptible bacteria. It is also prescribed for bacteremia and right-sided infective endocarditis. Patients often ask, 'What is Daptomycin used for?' This medication targets serious infections where other antibiotics may not be effective.

Side Effects

Common effects of Daptomycin may include reactions at the injection site, such as redness or swelling. Some patients may experience muscle pain, nausea, or dizziness. These effects vary and are not exhaustive; always consult a healthcare provider for personalized advice.

Precautions & Warnings

Daptomycin should be handled with care, ensuring proper storage and preparation. It is crucial to follow medical guidance for administration to avoid complications. Patients with known allergies to Daptomycin or similar antibiotics should inform their healthcare provider before use.

Avoid Interactions

Daptomycin may interact with other medications, including those that affect muscle function or the nervous system. Alcohol and certain supplements can also influence its effectiveness. Always disclose all medications and supplements to your healthcare provider to avoid potential interactions.

Frequently Asked Questions

Daptomycin is used to treat serious bacterial infections, including complicated skin infections and bloodstream infections.

Daptomycin is administered intravenously as a solution prepared from the lyophilized powder.

Common side effects may include injection site reactions, muscle pain, nausea, and dizziness.

Daptomycin may interact with other medications, so it's important to consult a healthcare provider before combining treatments.

Patients with known allergies to Daptomycin or similar antibiotics should avoid using this medication.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.